Income Statement DRTECH Corporation

Stocks

A214680

KR7214680001

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E. Other stock markets 2026-07-28			5-day change	1st Jan Change
836.00 ^KRW	-5.00%		-13.10%	-60.29%

06-23	DRTECH Corporation announced that it has received KRW 27 billion in funding	CI
06-10	DRTECH Corporation announced that it expects to receive KRW 27 billion in funding	CI

a5e2761de4abd77a42110aa22e.OQL8_Vx1ahEOxvWPuoPDzCpfs0K5t1ehzvXyRnZRs9E.S0elzBI7AGlD8Zqi1MTznFIe3Djvz2TCl8CUJzEd-55SRcqLCB0if0XzoA

Published financial data: DRTECH CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	70.28B	89.48B	92.44B	97.56B	116B
Other Revenues, Total	-	-10	-	-	-
Total Revenues	70.28B	89.48B	92.44B	97.56B	116B
Cost of Goods Sold, Total	38.4B	49.18B	50.09B	58.05B	74.32B
Gross Profit	31.87B	40.31B	42.35B	39.51B	41.98B
Selling General & Admin Expenses, Total	16.62B	21.88B	27.63B	29.49B	32.04B
Provision for Bad Debts	1.36B	-1.73B	-76.33M	208M	2.65B
R&D Expenses	11.02B	10.82B	11.52B	16.85B	16.16B
Depreciation & Amortization - (IS)	1.42B	1.97B	2.9B	3.92B	4.54B
Amortization of Goodwill and Intangible Assets - (IS)	700M	723M	526M	609M	528M
Other Operating Expenses	-	-	-	531M	-
Other Operating Expenses, Total	31.12B	33.67B	42.5B	51.62B	55.91B
Operating Income	759M	6.64B	-149M	-12.11B	-13.93B
Interest Expense, Total	-541M	-1.36B	-1.98B	-4.4B	-7.99B
Interest And Investment Income	486M	503M	901M	741M	494M
Net Interest Expenses	-55.02M	-856M	-1.08B	-3.66B	-7.5B
Income (Loss) On Equity Invest.	374M	-195M	-599M	-485M	-1.33B
Currency Exchange Gains (Loss)	1.7B	450M	331M	4.63B	1.75M
Other Non Operating Income (Expenses)	109M	513M	-667M	-1.8B	-997M
EBT, Excl. Unusual Items	2.89B	6.55B	-2.16B	-13.41B	-23.75B
Gain (Loss) On Sale Of Investments	-30.28M	-1.43B	1.14B	-4.25B	-1.56B
Gain (Loss) On Sale Of Assets	48.31M	103M	170M	69.34M	27.31M
Asset Writedown	-	-	-	-1.17B	-401M
Other Unusual Items	-	-163K	-	-	-
EBT, Incl. Unusual Items	2.9B	5.23B	-852M	-18.76B	-25.69B
Income Tax Expense	-1.05B	-722M	1.21B	530M	-1.66B
Earnings From Continuing Operations	3.95B	5.95B	-2.06B	-19.29B	-24.03B
Net Income to Company	3.95B	5.95B	-2.06B	-19.29B	-24.03B
Minority Interest	84.92M	22.49M	-186M	1.29M	2.12M
Net Income - (IS)	4.04B	5.97B	-2.25B	-19.29B	-24.03B
Preferred Dividend and Other Adjustments	-	8.52M	-500K	500K	-
Net Income to Common Incl Extra Items	4.04B	5.96B	-2.25B	-19.29B	-24.03B
Net Income to Common Excl. Extra Items	4.04B	5.96B	-2.25B	-19.29B	-24.03B
Per Share Items
Net EPS - Basic	74.4	103.49	-33.49	-261.85	-321.47
Basic EPS - Continuing Operations	74.4	103.49	-33.49	-261.85	-321.47
Basic Weighted Average Shares Outstanding	54.27M	57.62M	67.13M	73.67M	74.74M
Net EPS - Diluted	55.97	95.64	-34	-262	-321.47
Diluted EPS - Continuing Operations	55.97	95.64	-34	-262	-321.47
Diluted Weighted Average Shares Outstanding	72.98M	62.51M	67.13M	73.67M	74.74M
Normalized Basic EPS	34.79	71.44	-22.88	-113.78	-198.6
Normalized Diluted EPS	25.87	65.86	-22.88	-113.78	-198.6
Payout Ratio	-	-	-0.02	-0	-
Supplemental Items
EBITDA	6.33B	13.14B	7.83B	-2.13B	-2.87B
EBITA	1.46B	7.36B	377M	-11.5B	-13.4B
EBIT	759M	6.64B	-149M	-12.11B	-13.93B
EBITDAR	-	-	-	-	-
Effective Tax Rate - (Ratio)	-36.17	-13.81	-142.06	-2.83	6.47
Normalized Net Income	1.89B	4.12B	-1.54B	-8.38B	-14.84B
Supplemental Operating Expense Items
Advertising Expense	708M	781M	1.35B	1.56B	1.75B
Selling and Marketing Expenses	3.84B	4.75B	5.59B	7.38B	8.47B
General and Administrative Expenses	-	-	-	266M	139M
Research And Development Expense From Footnotes	11.02B	10.82B	11.52B	16.85B	16.16B
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Maintenance & Repair Expenses, Total	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	113M	156M	338M	984M	1.33B
Total Stock-Based Compensation	113M	156M	338M	984M	1.33B

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	10.73B	13.89B	12.17B	14.71B	21.18B
Short Term Investments	5.58B	7.53B	9.37B	4.51B	1.38B
Trading Asset Securities, Total	-	667M	2.86B	1.69B	4.74B
Total Cash And Short Term Investments	16.3B	22.09B	24.41B	20.91B	27.3B
Accounts Receivable, Total	20.48B	23.81B	30.26B	44.61B	52.69B
Other Receivables	147M	1.17B	651M	1.21B	2.24B
Notes Receivable	591M	50.15M	54.42M	677M	2.01B
Total Receivables	21.22B	25.03B	30.97B	46.5B	56.95B
Inventory	16.28B	27.11B	32.45B	35.27B	46.45B
Prepaid Expenses	2.89B	1.76B	2.87B	4.85B	3.26B
Other Current Assets, Total	1.85B	2.85B	6.84B	3.67B	3.85B
Total Current Assets	58.54B	78.84B	97.53B	111B	138B
Gross Property Plant And Equipment	41.35B	49.16B	75.78B	83.89B	78.73B
Accumulated Depreciation	-21.27B	-24.19B	-28.36B	-33.71B	-31.38B
Net Property Plant And Equipment	20.08B	24.97B	47.42B	50.18B	47.35B
Long-term Investments	4.69B	5.19B	5.9B	6.12B	5.16B
Goodwill	1.57B	1.57B	1.57B	401M	0
Other Intangibles, Total	2.11B	1.95B	2B	2.05B	1.93B
Accounts Receivable Long-Term	1.31B	717M	533M	201M	136M
Loans Receivable Long-Term	112M	110M	768M	955M	741M
Deferred Tax Assets Long-Term	3.93B	4.88B	3.71B	2.31B	2.61B
Deferred Charges Long-Term	0	0	-	-	-
Other Long-Term Assets, Total	1.56B	2.56B	4.59B	5.93B	6.14B
Total Assets	93.9B	121B	164B	179B	202B
Liabilities
Accounts Payable, Total	1.63B	3.44B	3.28B	4.77B	3.48B
Accrued Expenses, Total	1.09B	1.05B	1.34B	1.63B	1.82B
Short-term Borrowings	32.21B	32.15B	18.54B	21.27B	42.91B
Current Portion of Long-Term Debt	134M	49.95M	-	-	-
Current Portion of Leases	1.88B	2.81B	3.55B	4.89B	4.67B
Current Income Taxes Payable	85.64M	76.95M	45M	48.12M	-
Other Current Liabilities	3.88B	12.35B	5.3B	11.54B	14.94B
Total Current Liabilities	40.91B	51.93B	32.07B	44.16B	67.82B
Long-Term Debt	49.95M	-	13.32B	31.46B	23.33B
Long-Term Leases	4.11B	4.21B	22.31B	20.27B	17.51B
Pension & Other Post Retirement Benefits	3.3B	1.82B	4.17B	3.96B	4.21B
Deferred Tax Liability Non Current	143M	58.61M	24.71M	3.53M	-
Other Non Current Liabilities	946M	2.92B	7.53B	6.7B	12.24B
Total Liabilities	49.46B	60.94B	79.42B	107B	125B
Preferred Stock Non Redeemable	-	500M	500M	500M	500M
Total Preferred Equity	-	500M	500M	500M	500M
Common Stock, Total	5.66B	5.8B	7.25B	7.4B	8.35B
Additional Paid In Capital	36.02B	50.37B	77.26B	83.89B	109B
Retained Earnings	1.94B	4.31B	-148M	-19.99B	-43.89B
Treasury Stock	-252K	-252K	-252K	-252K	-252K
Comprehensive Income and Other	495M	-601M	-291M	972M	2.38B
Total Common Equity	44.11B	59.88B	84.07B	72.27B	76.24B
Minority Interest	326M	-537M	25.82M	28.05M	25.24M
Total Equity	44.44B	59.84B	84.59B	72.8B	76.77B
Total Liabilities And Equity	93.9B	121B	164B	179B	202B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	56.62M	58.02M	72.52M	74.02M	83.48M
ECS Total Common Shares Outstanding	56.62M	58.02M	72.52M	74.02M	83.48M
Book Value / Share	779.06	1.03K	1.16K	976.47	913.3
Tangible Book Value	40.43B	56.36B	80.5B	69.82B	74.31B
Tangible Book Value Per Share	714.06	971.31	1.11K	943.38	890.18
Total Debt	38.39B	39.22B	57.73B	77.89B	88.42B
Net Debt	22.08B	17.14B	33.32B	56.98B	61.12B
Debt Equivalent Oper. Leases	-	-	-	-	-
Minority Interest, Total (Incl. Fin. Div)	326M	-537M	25.82M	28.05M	25.24M
Equity Method Investments, Total	-	1.9B	5.3B	5.31B	3.98B
Inventories - Raw Materials, Total	7.79B	13.33B	15.31B	15.57B	22.94B
Inventories - Work In Process, Total	6.44B	9.55B	13.11B	13.9B	16.2B
Inventories - Finished Goods, Total	3.15B	5.24B	5.06B	7.18B	9.95B
Inventories - Others	-100	-870	-80	-1.83K	450
Land - (BS)	54.62M	-	-	-	-
Buildings, Total	345M	-	-	-	-
Machinery, Total	34.11B	39.35B	44.66B	52.2B	57.75B
Accumulated Allowance for Doubtful Accounts (Supple)	1.53B	839M	762M	980M	2.78B

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	4.04B	5.97B	-2.25B	-19.29B	-24.03B
Depreciation & Amortization - CF	4.88B	5.78B	7.45B	9.36B	10.53B
Amortization of Goodwill and Intangible Assets - (CF)	700M	723M	526M	609M	528M
Depreciation & Amortization, Total	5.58B	6.5B	7.98B	9.97B	11.06B
(Gain) Loss From Sale Of Asset	-48.31M	-103M	-170M	-69.34M	-27.31M
(Gain) Loss on Sale of Investments - (CF)	30.28M	973M	-1.14B	4.25B	1.56B
Asset Writedown & Restructuring Costs	-	-	-	1.17B	401M
(Income) Loss On Equity Investments - (CF)	-374M	195M	599M	485M	1.33B
Stock-Based Compensation (CF)	113M	156M	338M	984M	1.33B
Provision and Write-off of Bad Debts	-237M	-1.73B	-76.33M	208M	2.61B
Other Operating Activities, Total	677M	1.89B	5.67B	3.09B	9.39B
Change In Accounts Receivable	-4.99B	-4.11B	-5.97B	-9.6B	-8.16B
Change In Inventories	-2.49B	-10.69B	-5.33B	-2.68B	-12.21B
Change In Accounts Payable	-441M	1.82B	-343M	-736M	-1.75B
Change in Other Net Operating Assets	-2.86B	4.16B	-7.25B	-3.8B	-1.63B
Cash from Operations	-1.01B	5.04B	-7.94B	-16.03B	-20.13B
Capital Expenditure	-4.49B	-7.13B	-9.46B	-9.35B	-6.48B
Sale of Property, Plant, and Equipment	2.9B	410M	196M	35.47M	125M
Cash Acquisitions	-	-	-	-	-
Divestitures	-509M	-	-	-	-
Sale (Purchase) of Intangible assets	-64.31M	-666M	-500M	-305M	-290M
Investment in Marketable and Equity Securities, Total	1.72B	-3.7B	-4.13B	2.96B	1.98B
Net (Increase) Decrease in Loans Originated / Sold - Investing	11.86M	13.46M	182M	243M	101M
Other Investing Activities, Total	-211M	-826M	-1.77B	724M	-41.44M
Cash from Investing	-643M	-11.9B	-15.48B	-5.7B	-4.6B
Short Term Debt Issued, Total	247M	8.7B	6.93B	5.8B	6.5B
Long-Term Debt Issued, Total	-	-	20B	22.18B	22B
Total Debt Issued	247M	8.7B	26.93B	27.98B	28.5B
Short Term Debt Repaid, Total	-1.34B	-3.91B	-2.6B	-2.07B	-8.59B
Long-Term Debt Repaid, Total	-1.74B	-3.26B	-3.05B	-3.48B	-3.42B
Total Debt Repaid	-3.08B	-7.17B	-5.65B	-5.55B	-12.01B
Issuance of Common Stock	-	8.57B	939M	1.32B	15.09B
Repurchase of Common Stock	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-500K	-500K	-
Common & Preferred Stock Dividends Paid	-	-	-500K	-500K	-
Other Financing Activities, Total	-537M	-	-362M	-	-231M
Cash from Financing	-3.37B	10.1B	21.86B	23.75B	31.35B
Foreign Exchange Rate Adjustments	88.8M	-70.21M	-158M	503M	-145M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-10
Net Change in Cash	-4.93B	3.17B	-1.72B	2.53B	6.47B
Supplemental Items
Cash Interest Paid	501M	544M	1.13B	2.64B	3.13B
Cash Income Tax Paid (Refund)	140M	257M	243M	102M	144M
Levered Free Cash Flow	-8.23B	-2.12B	-26.29B	-18.17B	-26.06B
Unlevered Free Cash Flow	-7.89B	-1.27B	-25.05B	-15.42B	-21.07B
Change In Net Working Capital	9.5B	4.28B	23.32B	9.15B	17.98B
Net Debt Issued / Repaid	-2.83B	1.53B	21.28B	22.43B	16.49B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	0.51	3.87	-0.07	-4.41	-4.57
Return on Total Capital	0.58	4.56	-0.08	-5.16	-5.51
Return On Equity %	10.24	11.41	-2.86	-24.51	-32.13
Return on Common Equity	10.46	11.47	-3.12	-24.68	-32.36
Margin Analysis
Gross Profit Margin %	45.36	45.04	45.81	40.5	36.1
SG&A Margin	23.64	24.46	29.89	30.23	27.55
EBITDA Margin %	9.01	14.69	8.47	-2.19	-2.47
EBITA Margin %	2.08	8.23	0.41	-11.78	-11.52
EBIT Margin %	1.08	7.42	-0.16	-12.41	-11.98
Income From Continuing Operations Margin %	5.62	6.65	-2.23	-19.77	-20.66
Net Income Margin %	5.75	6.67	-2.43	-19.77	-20.66
Net Avail. For Common Margin %	5.75	6.66	-2.43	-19.77	-20.66
Normalized Net Income Margin	2.69	4.6	-1.66	-8.59	-12.76
Levered Free Cash Flow Margin	-11.7	-2.37	-28.44	-18.62	-22.41
Unlevered Free Cash Flow Margin	-11.22	-1.42	-27.1	-15.8	-18.11
Asset Turnover
Asset Turnover	0.76	0.83	0.65	0.57	0.61
Fixed Assets Turnover	3.28	3.97	2.55	2	2.38
Receivables Turnover (Average Receivables)	4.02	4.04	3.42	2.61	2.39
Inventory Turnover (Average Inventory)	2.59	2.27	1.68	1.71	1.82
Short Term Liquidity
Current Ratio	1.43	1.52	3.04	2.52	2.03
Quick Ratio	0.9	0.91	1.72	1.51	1.21
Operating Cash Flow to Current Liabilities	-0.02	0.1	-0.25	-0.36	-0.3
Days Sales Outstanding (Average Receivables)	90.71	90.34	106.76	140.44	152.68
Days Outstanding Inventory (Average Inventory)	140.98	161.02	216.99	213.48	200.66
Average Days Payable Outstanding	13.26	15.43	22.14	24.23	17.62
Cash Conversion Cycle (Average Days)	218.43	235.93	301.61	329.7	335.72
Long Term Solvency
Total Debt/Equity	86.38	65.55	68.24	106.99	115.19
Total Debt / Total Capital	46.35	39.59	40.56	51.69	53.53
LT Debt/Equity	9.36	7.04	42.12	71.05	53.2
Long-Term Debt / Total Capital	5.02	4.25	25.04	34.33	24.73
Total Liabilities / Total Assets	52.67	50.46	48.42	59.41	61.97
EBIT / Interest Expense	1.4	4.88	-0.08	-2.75	-1.74
EBITDA / Interest Expense	11.71	9.67	3.96	-0.48	-0.36
(EBITDA - Capex) / Interest Expense	3.42	4.42	-0.82	-2.61	-1.17
Total Debt / EBITDA	6.06	2.98	7.37	-36.49	-30.78
Net Debt / EBITDA	3.49	1.3	4.26	-26.7	-21.28
Total Debt / (EBITDA - Capex)	20.77	6.52	-35.48	-6.78	-9.46
Net Debt / (EBITDA - Capex)	11.95	2.85	-20.48	-4.96	-6.54
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	27.16	27.33	3.31	5.54	19.21
Gross Profit, 1 Yr. Growth %	48.79	26.45	5.07	-6.7	6.25
EBITDA, 1 Yr. Growth %	-739.84	107.46	-31.43	-127.26	34.6
EBITA, 1 Yr. Growth %	-129.98	404.78	-93.31	-3.15K	16.59
EBIT, 1 Yr. Growth %	-113.82	774.74	-103.03	8.03K	15.09
Earnings From Cont. Operations, 1 Yr. Growth %	-150.64	50.5	-134.67	835.33	24.56
Net Income, 1 Yr. Growth %	-155.85	47.89	-137.65	757.91	24.56
Normalized Net Income, 1 Yr. Growth %	-150.76	118.04	-147.75	445.87	39.94
Diluted EPS Before Extra, 1 Yr. Growth %	-139.69	70.88	-135.55	670.59	22.7
Accounts Receivable, 1 Yr. Growth %	41.76	16.26	27.09	47.41	18.12
Inventory, 1 Yr. Growth %	21.62	66.51	19.71	8.68	31.72
Net Property, Plant and Equip., 1 Yr. Growth %	-11.69	24.32	89.95	5.81	-5.63
Total Assets, 1 Yr. Growth %	2.28	28.63	35.8	9.35	12.56
Tangible Book Value, 1 Yr. Growth %	40.09	39.38	42.84	-13.26	6.42
Common Equity, 1 Yr. Growth %	33.28	35.73	40.41	-14.03	5.49
Cash From Operations, 1 Yr. Growth %	-35.85	-599.03	-257.54	101.92	25.63
Capital Expenditures, 1 Yr. Growth %	-29.83	58.93	32.64	-1.08	-30.77
Levered Free Cash Flow, 1 Yr. Growth %	101.26	-74.26	722.79	-30.89	43.46
Unlevered Free Cash Flow, 1 Yr. Growth %	110.59	-83.93	968.18	-38.46	36.66
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	21.2	27.24	14.69	4.42	12.17
Gross Profit, 2 Yr. CAGR %	20.57	37.17	15.26	-0.99	-0.44
EBITDA, 2 Yr. CAGR %	17.53	264.34	11.18	-56.77	-39.43
EBITA, 2 Yr. CAGR %	-6.56	23.01	-49.16	42.79	496.3
EBIT, 2 Yr. CAGR %	-26.32	9.97	-55.72	56.93	867.49
Earnings From Cont. Operations, 2 Yr. CAGR %	104.57	-12.7	-27.77	80.07	241.33
Net Income, 2 Yr. CAGR %	106.76	-9.12	-25.38	79.72	226.9
Normalized Net Income, 2 Yr. CAGR %	59.46	5.21	-9.82	61.44	210.91
Diluted EPS Before Extra, 2 Yr. CAGR %	78.11	-17.64	-22.06	65.52	207.49
Accounts Receivable, 2 Yr. CAGR %	10.13	28.38	21.55	36.87	31.95
Inventory, 2 Yr. CAGR %	12.65	42.31	41.18	14.06	19.65
Net Property, Plant and Equip., 2 Yr. CAGR %	21.69	4.78	53.67	41.77	-0.07
Total Assets, 2 Yr. CAGR %	15.03	14.7	32.17	21.86	10.94
Tangible Book Value, 2 Yr. CAGR %	6.37	39.73	41.1	11.31	-3.92
Common Equity, 2 Yr. CAGR %	8.66	34.5	38.05	9.87	-4.77
Cash From Operations, 2 Yr. CAGR %	-47.04	78.92	180.39	78.36	59.27
Capital Expenditures, 2 Yr. CAGR %	18.85	5.6	45.19	14.54	-17.25
Levered Free Cash Flow, 2 Yr. CAGR %	414.66	-28.02	78.77	138.45	-0.43
Unlevered Free Cash Flow, 2 Yr. CAGR %	278.2	-41.82	78.22	156.38	-8.3
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	16.27	23.21	18.7	11.55	9.13
Gross Profit, 3 Yr. CAGR %	16.83	22.5	25.5	7.42	1.37
EBITDA, 3 Yr. CAGR %	25.08	42.04	99.24	-30.42	-36.87
EBITA, 3 Yr. CAGR %	-6.9	63.96	-57.37	99.01	33.46
EBIT, 3 Yr. CAGR %	-21.55	68.08	-69.96	151.72	41.52
Earnings From Cont. Operations, 3 Yr. CAGR %	46.95	84.68	-35.83	69.62	59.25
Net Income, 3 Yr. CAGR %	48	84.91	-32.25	68.42	59.05
Normalized Net Income, 3 Yr. CAGR %	29.57	76.99	-25.54	64.35	66.5
Diluted EPS Before Extra, 3 Yr. CAGR %	30.23	75.67	-37.76	67.28	49.8
Accounts Receivable, 3 Yr. CAGR %	5.05	12.14	27.94	29.62	30.31
Inventory, 3 Yr. CAGR %	15.11	28.32	34.34	29.39	19.67
Net Property, Plant and Equip., 3 Yr. CAGR %	47.68	22.56	27.76	35.69	23.78
Total Assets, 3 Yr. CAGR %	23.54	19.4	21.34	24.07	18.68
Tangible Book Value, 3 Yr. CAGR %	10.99	16.39	40.76	19.97	9.66
Common Equity, 3 Yr. CAGR %	12.09	17.03	36.44	17.89	8.39
Cash From Operations, 3 Yr. CAGR %	-30.3	11.85	71.49	151.32	58.69
Capital Expenditures, 3 Yr. CAGR %	15.14	30.94	13.94	27.76	-3.16
Levered Free Cash Flow, 3 Yr. CAGR %	64.29	89.62	85.97	30.23	101.3
Unlevered Free Cash Flow, 3 Yr. CAGR %	66.29	31.99	88.41	25.03	107.88
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	13.91	18.19	15.63	15.32	16.04
Gross Profit, 5 Yr. CAGR %	12.81	20.4	16.2	12.5	14.4
EBITDA, 5 Yr. CAGR %	10.62	86.72	19.32	-14.18	23.75
EBITA, 5 Yr. CAGR %	-11.42	58.73	-26.91	47.08	22.47
EBIT, 5 Yr. CAGR %	-20.87	44.35	-37.59	53.98	20.47
Earnings From Cont. Operations, 5 Yr. CAGR %	55.45	26.8	10.61	82.82	25.21
Net Income, 5 Yr. CAGR %	56.12	26.9	12.54	82.82	27.15
Normalized Net Income, 5 Yr. CAGR %	29.2	26.46	12.08	62.38	31.89
Diluted EPS Before Extra, 5 Yr. CAGR %	33.91	16.8	6.06	71.54	17.92
Accounts Receivable, 5 Yr. CAGR %	8.23	9.67	11.36	21.44	29.53
Inventory, 5 Yr. CAGR %	10.37	20.04	24.9	22.42	28.26
Net Property, Plant and Equip., 5 Yr. CAGR %	42.52	39.72	50.05	29.91	15.8
Total Assets, 5 Yr. CAGR %	20.08	22.65	26.92	20.38	17.07
Tangible Book Value, 5 Yr. CAGR %	8.98	17.58	22.17	14.33	20.82
Common Equity, 5 Yr. CAGR %	10.07	17.7	21.83	14.11	18.16
Cash From Operations, 5 Yr. CAGR %	-32.41	12.16	21.63	34.81	66.49
Capital Expenditures, 5 Yr. CAGR %	17.64	23.73	26.33	24.12	0.26
Levered Free Cash Flow, 5 Yr. CAGR %	-	-17.52	69.93	125.65	44.85
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-25.3	70.96	94.67	41.26